Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy

dc.contributor.authors	Yildiz I, Bilici A, Karadurmuş N, Bayoğlu İV, Uysal M, Yildiz Y, Tanrıverdi Ö, Yazici O, Sürmeli Z Gökhan, T Nazim S, Bavbek S, Selçukbiricik F, Koca D, Basaran M
dc.date.accessioned	2020-02-27T08:26:12Z
dc.date.available	2020-02-27T08:26:12Z
dc.date.issued	2017
dc.identifier.citation	Yildiz I, Bilici A, Karadurmuş N, Bayoğlu İV, Uysal M, Yildiz Y, Tanrıverdi Ö, Yazici O, Sürmeli Z Gökhan, T Nazim S, Bavbek S, Selçukbiricik F, Koca D, Basaran M (2017). Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy. Tumori Journal, 14, -
dc.identifier.uri	https://doi.org/10.5301/tj.5000635
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65752
dc.title	Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
dc.identifier.volume	14
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	Tumori Journal
dc.identifier.doi	10.5301/tj.5000635
dc.contributor.author	Bayoğlu, İbrahim Vedat